| Literature DB >> 29146868 |
Chrystelle Aillaud1,2, Christophe Bosc1,2, Leticia Peris1,2, Anouk Bosson1,2, Pierre Heemeryck1,2, Juliette Van Dijk3,4, Julien Le Friec1,2, Benoit Boulan1,2, Frédérique Vossier1,2, Laura E Sanman5, Salahuddin Syed5, Neri Amara5, Yohann Couté6, Laurence Lafanechère7, Eric Denarier1,2,8, Christian Delphin1,2, Laurent Pelletier1,2, Sandrine Humbert1,2, Matthew Bogyo5, Annie Andrieux9,2,8, Krzysztof Rogowski3, Marie-Jo Moutin1,2.
Abstract
Reversible detyrosination of α-tubulin is crucial to microtubule dynamics and functions, and defects have been implicated in cancer, brain disorganization, and cardiomyopathies. The identity of the tubulin tyrosine carboxypeptidase (TCP) responsible for detyrosination has remained unclear. We used chemical proteomics with a potent irreversible inhibitor to show that the major brain TCP is a complex of vasohibin-1 (VASH1) with the small vasohibin binding protein (SVBP). VASH1 and its homolog VASH2, when complexed with SVBP, exhibited robust and specific Tyr/Phe carboxypeptidase activity on microtubules. Knockdown of vasohibins or SVBP and/or inhibitor addition in cultured neurons reduced detyrosinated α-tubulin levels and caused severe differentiation defects. Furthermore, knockdown of vasohibins disrupted neuronal migration in developing mouse neocortex. Thus, vasohibin/SVBP complexes represent long-sought TCP enzymes.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29146868 DOI: 10.1126/science.aao4165
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728